FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today reported financial results for the fiscal second quarter ended December 31, 2006. Highlights of the second quarter of fiscal 2007 and other Company initiatives include:
